The GLP-1 Dilemma: How Employers Can Take Control
Many employers are facing challenges in incorporating high-cost GLP-1 medications, such as Mounjaro, Ozempic, Rybelsus, Trulicity and Wegovy, into their group health plans, as they must balance the cost of the group health plan against the interests of participants and beneficiaries in the treatment. With prescriptions for these drugs cost around $1,000 a month, outlays…